Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SUMMER INFAN | SUMR | 9.64% |
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 5.76% |
| FEDERAL MOGU | FDML | 5.69% |
| NEW ORIENTAL | EDU | 5.44% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We have upgraded our recommendation on Hartford Financial Services Group Inc. ( ( HIG - Analyst Report ) ) to Neutral from Underperform prompted by its initiatives to increase operational and financial efficiency. Nevertheless, we are a bit concerned about the lower 2011 earning guidance provided by the company on December 8, 2011.
Hartford has been selling off its non-core businesses in order to focus on its core businesses, thereby improving the operating performance in the long run. During the past three months, Hartford announced an agreement to sell its subsidiary Hartford Life Private Placement to Philadelphia Financial Group Inc. and completed the sale of Federal Trust Corporation, to CenterState Banks, Inc. (CSFL) and Trumbull Services LLC to ExlService Holdings, Inc. ( EXLS - Snapshot Report ) .
Additionally, Harford realizes the need to improve its financial efficiencies and risk management functions. For this, the company signed a multi-year agreement with Accenture Plc. ( ACN - Snapshot Report ) , whereby the latter will provide management and technology consultancy services along with finance and accounting business process outsourcing services.
On the flip side, management expects to report a decline in both AARP direct and agency businesses in 2011 earnings release, which will contribute to the expected decline in the year’s written premium. Management also expects the statutory surplus in Life operations to continue declining through 2012. This is also reflected in management’s expectation of a single-digit growth rate in 2012.
Additionally, the net investment income of Hartford varies significantly with changes in market conditions, thereby largely impacting the company’s net income. With the ongoing weak market conditions, the poor investment results are expected to continue in 2012 and beyond. Moreover, low interest rates since the mid-2010 coupled with the poor economic scenario have prompted management to declare that the achievement of the previously announced ROE target of 11% will be delayed beyond the earlier goal of 2012-end.
The Zacks Consensus Estimate for Hartford’s fourth-quarter 2011 earnings is currently 61 cents per share, down about 42% from the year-ago quarter. Moreover, for 2011, the Zacks Consensus Estimate stands at $1.86 per share, down about 44% from 2010.
Currently, Hartford carries a Zacks #3 Rank, implying a short-term ‘Hold’ rating.
Read the full Snapshot Report on ACN
Read the full Analyst Report on HIG
Read the full Snapshot Report on EXLS